1049984-09-9 Usage
Description
(2S,4R)-4-(pyridin-4-ylMethyl)pyrrolidine-2-carboxylic acid is a chiral compound derived from pyrrolidine and pyridine, featuring a pyrrolidine ring with a pyridine methyl group at the fourth position and a carboxylic acid group at the second position. (2S,4R)-4-(pyridin-4-ylMethyl)pyrrolidine-2-carboxylic acid, with its two asymmetric centers, results in four possible stereoisomers, and it can serve as a building block in the synthesis of pharmaceuticals, agrochemicals, and other bioactive compounds due to its unique structure and potential biological activity.
Uses
Used in Pharmaceutical Industry:
(2S,4R)-4-(pyridin-4-ylMethyl)pyrrolidine-2-carboxylic acid is used as a building block for the synthesis of pharmaceuticals, leveraging its unique structure and potential biological activity to contribute to the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, (2S,4R)-4-(pyridin-4-ylMethyl)pyrrolidine-2-carboxylic acid is utilized as a component in the creation of agrochemicals, potentially enhancing the effectiveness of pesticides and other agricultural products.
Used in Bioactive Compounds Synthesis:
(2S,4R)-4-(pyridin-4-ylMethyl)pyrrolidine-2-carboxylic acid is employed as a key component in the synthesis of bioactive compounds, which may have various applications in medicine, agriculture, and other fields, due to its distinctive structural features and possible biological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1049984-09-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,9,9,8 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1049984-09:
(9*1)+(8*0)+(7*4)+(6*9)+(5*9)+(4*8)+(3*4)+(2*0)+(1*9)=189
189 % 10 = 9
So 1049984-09-9 is a valid CAS Registry Number.
1049984-09-9Relevant articles and documents
MERCAPTOACYL DERIVATIVES OF VARIOUS 4-SUBSTITUTED PROLINES
-
, (2008/06/13)
This invention is directed to compounds of the formula STR1 and various intermediates therefore. The final products possess useful hypotensive activity.
